Search

Tzu-Po Chuang

Anaplastic Lymphoma Kinase signaling stabilizes SLC3A2 expression via MARCH11 to promote neuroblastoma cell growth
ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib
ALK fusion NSCLC oncogenes promote survival and inhibit NK cell responses via SERPINB4 expression
Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC
ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation

Published with Hugo Blox Builder — the free, open source website builder that empowers creators.